Patient‐reported outcome measures in surgical patients with upper gastrointestinal cancers: A qualitative interview study
Background and Objectives Patients with pancreatic and gastroesophageal (PGE) cancers experience high symptom burden, but patient experience throughout multimodality treatment remains unclear. We aimed to delineate the experience and symptom burden of patients throughout their perioperative course....
Gespeichert in:
Veröffentlicht in: | Journal of surgical oncology 2024-07, Vol.130 (1), p.117-124 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 124 |
---|---|
container_issue | 1 |
container_start_page | 117 |
container_title | Journal of surgical oncology |
container_volume | 130 |
creator | Cass, Samuel H. Williams, Loretta A. Rajaram, Ravi Hirata, Yuki Rice, David Tzeng, Ching‐Wei D. Katz, Matthew H. G. Badgwell, Brian D. Wang, Xin Shelley Ikoma, Naruhiko |
description | Background and Objectives
Patients with pancreatic and gastroesophageal (PGE) cancers experience high symptom burden, but patient experience throughout multimodality treatment remains unclear. We aimed to delineate the experience and symptom burden of patients throughout their perioperative course.
Methods
Qualitative interviews were performed with 17 surgical patients with PGE cancer. Interview transcripts were analyzed and symptoms were ranked by frequency. An expert panel assessed the relevance of these symptom inventory items.
Results
Of the 17 patients included, 35% (n = 6) underwent gastrectomy, 30% (n = 5) underwent esophagectomy, and 35% (n = 6) underwent pancreatectomy; 76% (n = 13) received neoadjuvant systemic chemotherapy and/or chemoradiation. Overall, 32 symptoms were reported, and 19 were reported by over 20% of patients. An expert panel rated nine symptoms to be relevant or very relevant to PGE surgical patients. These symptoms (difficulty swallowing, heartburn/reflux, diarrhea, constipation, flushing/sweating, stomach feeling full, malaise, dizziness, or feeling cold) were added to the core MD Anderson Symptom Inventory (MDASI) if they were commonly reported or reached a threshold relevancy score.
Conclusions
In this qualitative study, we developed a provisional symptom inventory for patients undergoing surgery for PGE cancer. This symptom inventory module of the MDASI for PGE surgical patients will be psychometrically tested for validity and reliability. |
doi_str_mv | 10.1002/jso.27687 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3060749648</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3060749648</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3137-a18310b8455b2b4248e17e5645261b91b24be79bba92b1273848fb8b404038393</originalsourceid><addsrcrecordid>eNp10U1LHDEcBvBQWnS1HvoFJNBLPYzmbSeJN5G2tggK1fOQzP7XZpmZjHlxWXrpR-hn7Ccx27EeBE8J5JcnLw9CHyg5poSwk1X0x0zWSr5BM0p0XWmi1Vs0K2usElKTXbQX44oQonUtdtAuV1IrJuUM_bo2ycGQ_v7-E2D0IcEC-5xa3wPuwcQcIGI34DK5c63p8Dj5iNcu_cR5HCHgOxNT8G5IEJMbCmrN0EKIp_gM32fTuVQ2PQDeivDgYI1jyovNe_RuaboIB0_jPrr98vnm_KK6vPr67fzssmo55bIyVHFKrBLzuWVWMKGASpjXYs5qajW1TFiQ2lqjmaVMciXU0ioriCBccc330acpdwz-Ppc7Nr2LLXSdGcDn2HBSEynKz6hCP76gK59DedJWSa3LmYwXdTSpNvgYAyybMbjehE1DSbNtpCmNNP8aKfbwKTHbHhbP8n8FBZxMYO062Lye1Hz_cTVFPgLseZeJ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3079945223</pqid></control><display><type>article</type><title>Patient‐reported outcome measures in surgical patients with upper gastrointestinal cancers: A qualitative interview study</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Cass, Samuel H. ; Williams, Loretta A. ; Rajaram, Ravi ; Hirata, Yuki ; Rice, David ; Tzeng, Ching‐Wei D. ; Katz, Matthew H. G. ; Badgwell, Brian D. ; Wang, Xin Shelley ; Ikoma, Naruhiko</creator><creatorcontrib>Cass, Samuel H. ; Williams, Loretta A. ; Rajaram, Ravi ; Hirata, Yuki ; Rice, David ; Tzeng, Ching‐Wei D. ; Katz, Matthew H. G. ; Badgwell, Brian D. ; Wang, Xin Shelley ; Ikoma, Naruhiko</creatorcontrib><description>Background and Objectives
Patients with pancreatic and gastroesophageal (PGE) cancers experience high symptom burden, but patient experience throughout multimodality treatment remains unclear. We aimed to delineate the experience and symptom burden of patients throughout their perioperative course.
Methods
Qualitative interviews were performed with 17 surgical patients with PGE cancer. Interview transcripts were analyzed and symptoms were ranked by frequency. An expert panel assessed the relevance of these symptom inventory items.
Results
Of the 17 patients included, 35% (n = 6) underwent gastrectomy, 30% (n = 5) underwent esophagectomy, and 35% (n = 6) underwent pancreatectomy; 76% (n = 13) received neoadjuvant systemic chemotherapy and/or chemoradiation. Overall, 32 symptoms were reported, and 19 were reported by over 20% of patients. An expert panel rated nine symptoms to be relevant or very relevant to PGE surgical patients. These symptoms (difficulty swallowing, heartburn/reflux, diarrhea, constipation, flushing/sweating, stomach feeling full, malaise, dizziness, or feeling cold) were added to the core MD Anderson Symptom Inventory (MDASI) if they were commonly reported or reached a threshold relevancy score.
Conclusions
In this qualitative study, we developed a provisional symptom inventory for patients undergoing surgery for PGE cancer. This symptom inventory module of the MDASI for PGE surgical patients will be psychometrically tested for validity and reliability.</description><identifier>ISSN: 0022-4790</identifier><identifier>ISSN: 1096-9098</identifier><identifier>EISSN: 1096-9098</identifier><identifier>DOI: 10.1002/jso.27687</identifier><identifier>PMID: 38798277</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Esophageal cancer ; Gastric cancer ; Pancreatic cancer ; Patients ; patient‐reported outcomes ; qualitative research ; symptom burden</subject><ispartof>Journal of surgical oncology, 2024-07, Vol.130 (1), p.117-124</ispartof><rights>2024 Wiley Periodicals LLC.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3137-a18310b8455b2b4248e17e5645261b91b24be79bba92b1273848fb8b404038393</cites><orcidid>0000-0001-6035-7288 ; 0000-0002-9915-8355 ; 0000-0002-0283-6392 ; 0000-0003-3870-6968 ; 0000-0002-9825-9234</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjso.27687$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjso.27687$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38798277$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cass, Samuel H.</creatorcontrib><creatorcontrib>Williams, Loretta A.</creatorcontrib><creatorcontrib>Rajaram, Ravi</creatorcontrib><creatorcontrib>Hirata, Yuki</creatorcontrib><creatorcontrib>Rice, David</creatorcontrib><creatorcontrib>Tzeng, Ching‐Wei D.</creatorcontrib><creatorcontrib>Katz, Matthew H. G.</creatorcontrib><creatorcontrib>Badgwell, Brian D.</creatorcontrib><creatorcontrib>Wang, Xin Shelley</creatorcontrib><creatorcontrib>Ikoma, Naruhiko</creatorcontrib><title>Patient‐reported outcome measures in surgical patients with upper gastrointestinal cancers: A qualitative interview study</title><title>Journal of surgical oncology</title><addtitle>J Surg Oncol</addtitle><description>Background and Objectives
Patients with pancreatic and gastroesophageal (PGE) cancers experience high symptom burden, but patient experience throughout multimodality treatment remains unclear. We aimed to delineate the experience and symptom burden of patients throughout their perioperative course.
Methods
Qualitative interviews were performed with 17 surgical patients with PGE cancer. Interview transcripts were analyzed and symptoms were ranked by frequency. An expert panel assessed the relevance of these symptom inventory items.
Results
Of the 17 patients included, 35% (n = 6) underwent gastrectomy, 30% (n = 5) underwent esophagectomy, and 35% (n = 6) underwent pancreatectomy; 76% (n = 13) received neoadjuvant systemic chemotherapy and/or chemoradiation. Overall, 32 symptoms were reported, and 19 were reported by over 20% of patients. An expert panel rated nine symptoms to be relevant or very relevant to PGE surgical patients. These symptoms (difficulty swallowing, heartburn/reflux, diarrhea, constipation, flushing/sweating, stomach feeling full, malaise, dizziness, or feeling cold) were added to the core MD Anderson Symptom Inventory (MDASI) if they were commonly reported or reached a threshold relevancy score.
Conclusions
In this qualitative study, we developed a provisional symptom inventory for patients undergoing surgery for PGE cancer. This symptom inventory module of the MDASI for PGE surgical patients will be psychometrically tested for validity and reliability.</description><subject>Esophageal cancer</subject><subject>Gastric cancer</subject><subject>Pancreatic cancer</subject><subject>Patients</subject><subject>patient‐reported outcomes</subject><subject>qualitative research</subject><subject>symptom burden</subject><issn>0022-4790</issn><issn>1096-9098</issn><issn>1096-9098</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp10U1LHDEcBvBQWnS1HvoFJNBLPYzmbSeJN5G2tggK1fOQzP7XZpmZjHlxWXrpR-hn7Ccx27EeBE8J5JcnLw9CHyg5poSwk1X0x0zWSr5BM0p0XWmi1Vs0K2usElKTXbQX44oQonUtdtAuV1IrJuUM_bo2ycGQ_v7-E2D0IcEC-5xa3wPuwcQcIGI34DK5c63p8Dj5iNcu_cR5HCHgOxNT8G5IEJMbCmrN0EKIp_gM32fTuVQ2PQDeivDgYI1jyovNe_RuaboIB0_jPrr98vnm_KK6vPr67fzssmo55bIyVHFKrBLzuWVWMKGASpjXYs5qajW1TFiQ2lqjmaVMciXU0ioriCBccc330acpdwz-Ppc7Nr2LLXSdGcDn2HBSEynKz6hCP76gK59DedJWSa3LmYwXdTSpNvgYAyybMbjehE1DSbNtpCmNNP8aKfbwKTHbHhbP8n8FBZxMYO062Lye1Hz_cTVFPgLseZeJ</recordid><startdate>202407</startdate><enddate>202407</enddate><creator>Cass, Samuel H.</creator><creator>Williams, Loretta A.</creator><creator>Rajaram, Ravi</creator><creator>Hirata, Yuki</creator><creator>Rice, David</creator><creator>Tzeng, Ching‐Wei D.</creator><creator>Katz, Matthew H. G.</creator><creator>Badgwell, Brian D.</creator><creator>Wang, Xin Shelley</creator><creator>Ikoma, Naruhiko</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-6035-7288</orcidid><orcidid>https://orcid.org/0000-0002-9915-8355</orcidid><orcidid>https://orcid.org/0000-0002-0283-6392</orcidid><orcidid>https://orcid.org/0000-0003-3870-6968</orcidid><orcidid>https://orcid.org/0000-0002-9825-9234</orcidid></search><sort><creationdate>202407</creationdate><title>Patient‐reported outcome measures in surgical patients with upper gastrointestinal cancers: A qualitative interview study</title><author>Cass, Samuel H. ; Williams, Loretta A. ; Rajaram, Ravi ; Hirata, Yuki ; Rice, David ; Tzeng, Ching‐Wei D. ; Katz, Matthew H. G. ; Badgwell, Brian D. ; Wang, Xin Shelley ; Ikoma, Naruhiko</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3137-a18310b8455b2b4248e17e5645261b91b24be79bba92b1273848fb8b404038393</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Esophageal cancer</topic><topic>Gastric cancer</topic><topic>Pancreatic cancer</topic><topic>Patients</topic><topic>patient‐reported outcomes</topic><topic>qualitative research</topic><topic>symptom burden</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cass, Samuel H.</creatorcontrib><creatorcontrib>Williams, Loretta A.</creatorcontrib><creatorcontrib>Rajaram, Ravi</creatorcontrib><creatorcontrib>Hirata, Yuki</creatorcontrib><creatorcontrib>Rice, David</creatorcontrib><creatorcontrib>Tzeng, Ching‐Wei D.</creatorcontrib><creatorcontrib>Katz, Matthew H. G.</creatorcontrib><creatorcontrib>Badgwell, Brian D.</creatorcontrib><creatorcontrib>Wang, Xin Shelley</creatorcontrib><creatorcontrib>Ikoma, Naruhiko</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of surgical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cass, Samuel H.</au><au>Williams, Loretta A.</au><au>Rajaram, Ravi</au><au>Hirata, Yuki</au><au>Rice, David</au><au>Tzeng, Ching‐Wei D.</au><au>Katz, Matthew H. G.</au><au>Badgwell, Brian D.</au><au>Wang, Xin Shelley</au><au>Ikoma, Naruhiko</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Patient‐reported outcome measures in surgical patients with upper gastrointestinal cancers: A qualitative interview study</atitle><jtitle>Journal of surgical oncology</jtitle><addtitle>J Surg Oncol</addtitle><date>2024-07</date><risdate>2024</risdate><volume>130</volume><issue>1</issue><spage>117</spage><epage>124</epage><pages>117-124</pages><issn>0022-4790</issn><issn>1096-9098</issn><eissn>1096-9098</eissn><abstract>Background and Objectives
Patients with pancreatic and gastroesophageal (PGE) cancers experience high symptom burden, but patient experience throughout multimodality treatment remains unclear. We aimed to delineate the experience and symptom burden of patients throughout their perioperative course.
Methods
Qualitative interviews were performed with 17 surgical patients with PGE cancer. Interview transcripts were analyzed and symptoms were ranked by frequency. An expert panel assessed the relevance of these symptom inventory items.
Results
Of the 17 patients included, 35% (n = 6) underwent gastrectomy, 30% (n = 5) underwent esophagectomy, and 35% (n = 6) underwent pancreatectomy; 76% (n = 13) received neoadjuvant systemic chemotherapy and/or chemoradiation. Overall, 32 symptoms were reported, and 19 were reported by over 20% of patients. An expert panel rated nine symptoms to be relevant or very relevant to PGE surgical patients. These symptoms (difficulty swallowing, heartburn/reflux, diarrhea, constipation, flushing/sweating, stomach feeling full, malaise, dizziness, or feeling cold) were added to the core MD Anderson Symptom Inventory (MDASI) if they were commonly reported or reached a threshold relevancy score.
Conclusions
In this qualitative study, we developed a provisional symptom inventory for patients undergoing surgery for PGE cancer. This symptom inventory module of the MDASI for PGE surgical patients will be psychometrically tested for validity and reliability.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>38798277</pmid><doi>10.1002/jso.27687</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0001-6035-7288</orcidid><orcidid>https://orcid.org/0000-0002-9915-8355</orcidid><orcidid>https://orcid.org/0000-0002-0283-6392</orcidid><orcidid>https://orcid.org/0000-0003-3870-6968</orcidid><orcidid>https://orcid.org/0000-0002-9825-9234</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-4790 |
ispartof | Journal of surgical oncology, 2024-07, Vol.130 (1), p.117-124 |
issn | 0022-4790 1096-9098 1096-9098 |
language | eng |
recordid | cdi_proquest_miscellaneous_3060749648 |
source | Wiley Online Library Journals Frontfile Complete |
subjects | Esophageal cancer Gastric cancer Pancreatic cancer Patients patient‐reported outcomes qualitative research symptom burden |
title | Patient‐reported outcome measures in surgical patients with upper gastrointestinal cancers: A qualitative interview study |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T03%3A13%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Patient%E2%80%90reported%20outcome%20measures%20in%20surgical%20patients%20with%20upper%20gastrointestinal%20cancers:%20A%20qualitative%20interview%20study&rft.jtitle=Journal%20of%20surgical%20oncology&rft.au=Cass,%20Samuel%20H.&rft.date=2024-07&rft.volume=130&rft.issue=1&rft.spage=117&rft.epage=124&rft.pages=117-124&rft.issn=0022-4790&rft.eissn=1096-9098&rft_id=info:doi/10.1002/jso.27687&rft_dat=%3Cproquest_cross%3E3060749648%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3079945223&rft_id=info:pmid/38798277&rfr_iscdi=true |